olprinone and Atrial Fibrillation

olprinone has been researched along with Atrial Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, M; Maeda, H; Nojiri, T; Okumura, M; Ose, N; Susaki, Y; Takeuchi, Y; Yamamoto, K	1

Trials

1 trial(s) available for olprinone and Atrial Fibrillation

Article	Year
A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer. Chest, 2015, Volume: 148, Issue:5 Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; Incidence; Japan; Lung Neoplasms; Male; Phosphodiesterase 3 Inhibitors; Pneumonectomy; Postoperative Complications; Prospective Studies; Pyridones; Treatment Outcome	2015

Article

Year

A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer.

Chest, 2015, Volume: 148, Issue:5

Topics: Aged; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; Incidence; Japan; Lung Neoplasms; Male; Phosphodiesterase 3 Inhibitors; Pneumonectomy; Postoperative Complications; Prospective Studies; Pyridones; Treatment Outcome

2015